Skip to main
JNJ

JNJ Stock Forecast & Price Target

JNJ Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 32%
Hold 37%
Sell 0%
Strong Sell 0%

Bulls say

Johnson & Johnson is a strong player in the healthcare industry with a diverse portfolio and a focus on innovative medicines and MedTech. Their recent success with bispecifics and upcoming catalysts in global commercialization, along with a plan to separate their orthopedics business, suggest potential for long-term growth. The company also boasts a commitment to high standards and diversity in management, but ongoing litigations may pose challenges in the near future.

Bears say

Johnson & Johnson is facing significant headwinds from potential loss of exclusivity for certain drugs, as well as potential challenges in its pharmaceutical pipeline gaining traction. The company's focus on M&A also brings along risks related to price paid and integration, and JNJ is currently facing ongoing litigations that could have a negative impact on its financials. Overall, these factors lead to a negative outlook for the company's stock.

JNJ has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Johnson & Johnson (JNJ) Forecast

Analysts have given JNJ a Buy based on their latest research and market trends.

According to 19 analysts, JNJ has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $260.16, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $260.16, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Johnson & Johnson (JNJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.